Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""adults"" wg kryterium: Temat


Tytuł:
Changes of B cell subsets in different types of diabetes and its effect on the progression of latent autoimmune diabetes in adults.
Autorzy:
Wu P; Department of Clinical Laboratory, Women's Hospital, School of Medicine Zhejiang University, Hangzhou, Zhejiang, 310006, China.
Song Y; Geriatric Medicine Center, Department of Endocrinology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, 310014, China.
Chen Z; Department of Clinical Laboratory, Hangzhou Lin'an Third People's Hospital, Hangzhou, Zhejiang, 311311, China.
Xia J; Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, 310014, China. andisky_.
Zhou Y; Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, 310014, China. .; Key Laboratory of Biomarkers and In Vitro Diagnosis Translation of Zhejiang province, No.182 Tianmushan Road, Xihu District, Hangzhou, Zhejiang, 310063, China. .
Pokaż więcej
Źródło:
Endocrine [Endocrine] 2024 Mar; Vol. 83 (3), pp. 624-635. Date of Electronic Publication: 2023 Sep 27.
Typ publikacji:
Journal Article
MeSH Terms:
Latent Autoimmune Diabetes in Adults*
B-Lymphocyte Subsets*
Diabetes Mellitus, Type 1*/genetics
Glucose Intolerance*
Adult ; Humans ; Autoantibodies ; T-Lymphocytes ; Glutamate Decarboxylase
Czasopismo naukowe
Tytuł:
Does a prior diagnosis of infectious disease confer an increased risk of latent autoimmune diabetes in adults?
Autorzy:
Edstorp J; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Rossides M; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Respiratory Medicine and Allergy, Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden.
Ahlqvist E; Department of Clinical Sciences in Malmö, Clinical Research Centre, Lund University, Malmö, Sweden.
Rasouli B; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Tuomi T; Department of Clinical Sciences in Malmö, Clinical Research Centre, Lund University, Malmö, Sweden.; Institute for Molecular Medicine Finland, Helsinki University, Helsinki, Finland.; Division of Endocrinology, Abdominal Center, Helsinki University Hospital, Helsinki, Finland.; Research Program for Diabetes and Obesity, University of Helsinki, Helsinki, Finland.; Folkhälsan Research Center, Helsinki, Finland.
Carlsson S; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Pokaż więcej
Źródło:
Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2024 Mar; Vol. 40 (3), pp. e3758. Date of Electronic Publication: 2023 Dec 16.
Typ publikacji:
Journal Article
MeSH Terms:
Latent Autoimmune Diabetes in Adults*/epidemiology
Diabetes Mellitus, Type 2*/epidemiology
Diabetes Mellitus, Type 1*/epidemiology
Communicable Diseases*/complications
Adult ; Child ; Humans ; Case-Control Studies ; Autoantibodies ; Glutamate Decarboxylase
Czasopismo naukowe
Tytuł:
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version).
Autorzy:
Shimada A; Department of Endocrinology and Diabetes, School of Medicine, Saitama Medical University, Saitama, Japan.
Kawasaki E; Diabetes Center, Shin-Koga Hospital, Fukuoka, Japan.
Abiru N; Midori Clinic, Nagasaki, Japan.
Awata T; Pancreatic Islet Cell Transplantation Center, National Center for Global Health and Medicine, Tokyo, Japan.
Oikawa Y; Department of Endocrinology and Diabetes, School of Medicine, Saitama Medical University, Saitama, Japan.
Osawa H; Department of Diabetes and Molecular Genetics, Ehime University Graduate School of Medicine, Ehime, Japan.
Kajio H; Department of Diabetes, Endocrinology and Metabolism, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
Kozawa J; Department of Diabetes Care Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
Takahashi K; Department of Basic Nursing Science, School of Nursing, Iwate Prefectural University, Iwate, Japan.
Chujo D; Center for Clinical Research, Toyama University Hospital, Toyama, Japan.
Noso S; Department of Endocrinology, Metabolism and Diabetes, Kindai University Faculty of Medicine, Osaka, Japan.
Fukui T; Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine, Tokyo, Japan.
Miura J; Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Yasuda K; Department of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, Japan.
Yasuda H; Department of Public Health, Division of Health Sciences, Kobe University Graduate School of Health Sciences, Hyogo, Japan.
Imagawa A; Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Ikegami H; Department of Endocrinology, Metabolism and Diabetes, Kindai University Faculty of Medicine, Osaka, Japan.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2024 Feb; Vol. 15 (2), pp. 254-257. Date of Electronic Publication: 2024 Jan 07.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*
Hyperglycemia*
Latent Autoimmune Diabetes in Adults*
Female ; Humans ; Japan ; Insulin/therapeutic use ; Autoantibodies
Czasopismo naukowe
Tytuł:
Association of human leukocyte antigen (HLA) footprints with the comorbidity of latent autoimmune diabetes in adults (LADA) and hepatitis C virus (HCV) infection: A multicenter cross-sectional study.
Autorzy:
Ding Y; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Ministry of Education), Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Zhang P; Xiangya School of Public Health, Hunan Children's Hospital Affiliated with The Xiangya School of Medicine, Central South University, Changsha, China.
Deng T; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Ministry of Education), Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Yan X; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Ministry of Education), Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Zhang M; Department of Hepatology and Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, China.
Xie Z; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Ministry of Education), Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Huang G; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Ministry of Education), Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Wang P; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Ministry of Education), Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Cai T; Xiangya School of Public Health, Hunan Children's Hospital Affiliated with The Xiangya School of Medicine, Central South University, Changsha, China.
Zhang X; Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
Xiao X; Department of Hepatology and Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, China.
Xia Y; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Ministry of Education), Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Liu B; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Ministry of Education), Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Peng Y; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Ministry of Education), Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Tang X; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Ministry of Education), Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Hu M; Department of Clinical Laboratory, The Second Xiangya Hospital, Central South University, Changsha, China.
Xiao Y; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Ministry of Education), Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Li X; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Ministry of Education), Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Clercq E; Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Li G; Xiangya School of Public Health, Hunan Children's Hospital Affiliated with The Xiangya School of Medicine, Central South University, Changsha, China. Electronic address: .
Zhou Z; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Ministry of Education), Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China. Electronic address: .
Pokaż więcej
Źródło:
Diabetes & metabolic syndrome [Diabetes Metab Syndr] 2024 Jan; Vol. 18 (1), pp. 102939. Date of Electronic Publication: 2023 Dec 29.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 1*/epidemiology
Diabetes Mellitus, Type 1*/genetics
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/epidemiology
Diabetes Mellitus, Type 2*/genetics
Latent Autoimmune Diabetes in Adults*/epidemiology
Latent Autoimmune Diabetes in Adults*/genetics
Hepatitis C*/complications
Hepatitis C*/epidemiology
Hepatitis C*/genetics
Adult ; Humans ; Hepacivirus/genetics ; Cross-Sectional Studies ; Genetic Predisposition to Disease ; Haplotypes ; HLA Antigens/genetics ; Comorbidity ; Gene Frequency
Czasopismo naukowe
Tytuł:
Use of a type 1 genetic risk score for classification of diabetes type in young Australian adults: the Fremantle Diabetes Study Phase II.
Autorzy:
Davis TME; Medical School, University of Western Australia, Fremantle Hospital, Fremantle, Western Australia, Australia.; Department of Endocrinology and Diabetes, Fiona Stanley and Fremantle Hospitals Group, Perth, Western Australia, Australia.
Peters KE; Medical School, University of Western Australia, Fremantle Hospital, Fremantle, Western Australia, Australia.; Proteomics International, Perth, Western Australia, Australia.
Davis W; Medical School, University of Western Australia, Fremantle Hospital, Fremantle, Western Australia, Australia.
Pokaż więcej
Źródło:
Internal medicine journal [Intern Med J] 2024 Mar; Vol. 54 (3), pp. 494-498. Date of Electronic Publication: 2024 Jan 15.
Typ publikacji:
Clinical Trial, Phase II; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*
Diabetes Mellitus, Type 1*
Latent Autoimmune Diabetes in Adults*
Australasian People*
Adult ; Humans ; Genetic Risk Score ; C-Peptide/genetics ; Australia ; Autoantibodies
Czasopismo naukowe
Tytuł:
Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals.
Autorzy:
Song R; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Xie L; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Ding J; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Chen Y; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Zou H; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Pang H; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Peng Y; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Xia Y; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Xie Z; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Li X; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Xiao Y; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Zhou Z; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Hu J; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2024 Jan; Vol. 15 (1), pp. 34-43. Date of Electronic Publication: 2023 Dec 02.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*/epidemiology
Diabetes Mellitus, Type 1*/genetics
Diabetes Mellitus, Type 1*/diagnosis
Diabetes Mellitus, Type 2*/epidemiology
Diabetes Mellitus, Type 2*/genetics
Latent Autoimmune Diabetes in Adults*
Adult ; Humans ; C-Peptide ; Polymorphism, Genetic ; China/epidemiology ; Autoantibodies
Czasopismo naukowe
Tytuł:
The worldwide prevalence of latent autoimmune diabetes of adults among adult-onset diabetic individuals: a systematic review and meta-analysis.
Autorzy:
Ramu D; Department of Human Genetics, Sri Ramachandra Institute of Higher Education and Research, Chennai, India.
Ramaswamy S; Bioscience Research Foundation, Chennai, India.
Rao S; Department of Engineering Design, Indian Institute of Technology- Madras, Chennai, India.
Paul SFD; Department of Human Genetics, Sri Ramachandra Institute of Higher Education and Research, Chennai, India. .
Pokaż więcej
Źródło:
Endocrine [Endocrine] 2023 Oct; Vol. 82 (1), pp. 28-41. Date of Electronic Publication: 2023 Jul 10.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/epidemiology
Latent Autoimmune Diabetes in Adults*/epidemiology
Diabetes Mellitus, Type 1*/epidemiology
Glucose Intolerance*
Adult ; Humans ; Prevalence ; Europe
Czasopismo naukowe
Tytuł:
A 1-year pilot study of intralymphatic injections of GAD-alum in individuals with latent autoimmune diabetes in adults (LADA) with signs of high immunity: No safety concerns and resemblance to juvenile type 1 diabetes.
Autorzy:
Hals IK; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Endocrinology, Clinic of Medicine, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Research, Nord-Trøndelag Hospital Trust, Levanger, Norway.
Balasuriya C; Department of Endocrinology, Clinic of Medicine, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Casas R; Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.
Ludvigsson J; Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.; Crown Princess Victoria Children's Hospital, Linköping, Sweden.
Björklund A; Department of Molecular medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Center for Diabetes, Academic Specialist Center, Stockholm, Sweden.
Grill V; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Pokaż więcej
Źródło:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Nov; Vol. 25 (11), pp. 3400-3409. Date of Electronic Publication: 2023 Aug 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 1*/therapy
Glucose Intolerance*/drug therapy
Glutamate Decarboxylase*/adverse effects
Glutamate Decarboxylase*/therapeutic use
Latent Autoimmune Diabetes in Adults*/drug therapy
Adult ; Humans ; Middle Aged ; Autoantibodies ; Injections, Intralymphatic ; Leukocytes, Mononuclear ; Pilot Projects
Czasopismo naukowe
Tytuł:
The relationship between red blood cell distribution width and islet β-cell function indexes in patients with latent autoimmune diabetes in adults.
Autorzy:
Fu X; 1Department of Endocrinology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China.
Tan Q; 1Department of Endocrinology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China.
Wei W; 1Department of Endocrinology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China.
Ding S; 1Department of Endocrinology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China.
Wang Z; 1Department of Endocrinology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China. .
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2023 Aug 24; Vol. 23 (1), pp. 180. Date of Electronic Publication: 2023 Aug 24.
Typ publikacji:
Journal Article
MeSH Terms:
Latent Autoimmune Diabetes in Adults*
Diabetes Mellitus, Type 1*
Glucose Intolerance*
Adult ; Humans ; Male ; C-Peptide ; Cross-Sectional Studies ; Glycated Hemoglobin ; Erythrocytes
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies